Scotia Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,726
Closed -$569K 796
2019
Q3
$569K Sell
5,726
-1,195
-17% -$114K 0.01% 489
2019
Q2
$640K Sell
6,921
-19,520
-74% -$1.85M 0.01% 482
2019
Q1
$2.49M Sell
26,441
-8,542
-24% -$747K 0.03% 248
2018
Q4
$2.24M Sell
34,983
-10,126
-22% -$747K 0.03% 249
2018
Q3
$4.04M Sell
45,109
-18,829
-29% -$1.66M 0.05% 200
2018
Q2
$5.67M Buy
63,938
+196
+0.3% +$16.3K 0.08% 150
2018
Q1
$5.68M Sell
63,742
-5,264
-8% -$505K 0.08% 150
2017
Q4
$7.2M Sell
69,006
-1,412
-2% -$159K 0.1% 133
2017
Q3
$10.3M Buy
70,418
+961
+1% +$131K 0.15% 101
2017
Q2
$9.02M Buy
69,457
+12,058
+21% +$1.48M 0.15% 98
2017
Q1
$7.15M Buy
57,399
+1,986
+4% +$238K 0.12% 119
2016
Q4
$6.42M Sell
55,413
-4,495
-8% -$501K 0.1% 142
2016
Q3
$6.23M Buy
59,908
+8,749
+17% +$947K 0.11% 134
2016
Q2
$5.05M Buy
51,159
+7,934
+18% +$821K 0.1% 140
2016
Q1
$4.33M Sell
43,225
-12,266
-22% -$1.26M 0.09% 132
2015
Q4
$6.65M Hold
55,491
0.15% 110
2015
Q3
$6M Buy
55,491
+1,924
+4% +$239K 0.14% 117
2015
Q2
$6.14M Sell
53,567
-1,218
-2% -$139K 0.12% 129
2015
Q1
$6.32M Buy
54,785
+11,826
+28% +$1.41M 0.16% 102
2014
Q4
$4.81M Sell
42,959
-997
-2% -$105K 0.13% 117
2014
Q3
$4.17M Buy
43,956
+25,682
+141% +$2.32M 0.09% 134
2014
Q2
$3.14M Sell
18,274
-10,562
-37% -$803K 0.07% 157
2014
Q1
$2.01M Buy
28,836
+22,076
+327% +$1.75M 0.04% 197
2013
Q4
$571K Buy
6,760
+1,000
+17% +$79.1K 0.01% 345
2013
Q3
$444K Buy
5,760
+860
+18% +$60.3K 0.01% 350
2013
Q2
$287K Buy
+4,900
New +$295K 0.01% 373

Other funds holding CELG

Scotia Capital's CELG Position: Q4 2019 in Review

Scotia Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,726 shares — an estimated $569K sold.

Scotia Capital first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $10.3M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Scotia Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Scotia Capital sold 5,726 Celgene Corp shares in Q4 2019, an estimated $569K.
  • Scotia Capital first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Scotia Capital's Celgene Corp position peaked at $10.3M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Scotia Capital's 13F filing for Q4 2019, filed 13 Feb 2020.